Clinical trial

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma…

NCT00199082 · Nicola Goekbuget, Other · Completed

Key facts

NCT number NCT00199082
Title Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
Official title Multicenter Study to Optimise Therapy of B-ALL, Burkitt's NHL and High-Grade Non-Hodgkin's Lymphoma in Adults (Amend 7)
Lead sponsor Nicola Goekbuget, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Neoplasms, Lymphoblastic Lymphoma, Large Cell Anaplastic Lymphoma
Intervention type Drug, Procedure
Interventions Adriamycin, Cyclophosphamide, Cytarabine, Dexamethasone/Prednisolone, VP16, Ifosfamide, Methotrexate, G-CSF, Rituximab, Vincristine/Vindesine and 1 more
Enrollment 650
Start date Jul 1, 2002
Primary completion Jun 1, 2010
Completion Jun 1, 2010
First posted Sep 20, 2005
Last update posted Aug 19, 2022
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies